Interfascial effectiveness of ultrasound-guided blocking in transurethral resection of bladder tumor

Consorci Mar Parc de Salut de Barcelona (Parc de Salut MAR)0 个研究点开始时间: 2015年9月11日最近更新: 2015年11月16日

适应症

试验速览

暂无简介。

•1. Adult patients of both genre aged between 18 and 85 years, BMI less than 40.
•2. Bladder tumor diagnosed by ultrasound and / or flexible cystoscopy candidate for surgery transurethral resection of bladder tumor side face within three months of diagnosis.
•3. Single or multi-level lesion located anterior quadrant of the side faces bladder.
•4. Clinical indication for transurethral resection (TUR) of bladder tumor.
•5. Patients who signed informed consent indicating that they have been informed of all pertinent aspects of the trial.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 30
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 52

•1. Physical State assessed by ASA> 4 and / or ECOG> 4
•2. Allergy or hypersensitivity to lidocaine or any of the excipients of the study drug.
•3. Pregnant or breast-feeding.
•4. Participation in a clinical drug research before 3 months in pre-drug administration.
•5. Concomitant use of the following drugs: amiodarone, disopyramide, phenobarbital, phenytoin, monoaminooxidas inhibitors.
•6. Subjects with contraindications for regional anesthesia: patient refusal, skin infection, severe neurology pathology, severe thrombocytopenia (platelet count <100,000) receiving both treatment groups.

发起方